Evidence map›Paper›PMID 42649218›Full record

ArticleNature communications2026

Author Correction: Stringent selection drives convergence toward omicron-like SARS-CoV-2 receptor-binding motifs.

Aviv Shoshany, Ruojin Tian, Miguel Padilla-Blanco, Adam Hruška, Aditi Konar, Katarína Baxová, Eyal Zoler, Martin Mokrejš, Gideon Schreiber, Jiří Zahradník

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Aviv Shoshany *Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Ruojin Tian *First Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia.
Miguel Padilla-Blanco *First Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia.ORCID http://orcid.org/0000-0002-4820-6417
Adam HruškaFirst Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia.
Aditi KonarFirst Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia.
Katarína BaxováFirst Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia.
Eyal ZolerDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0009-0007-6169-9723
Martin MokrejšFirst Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia.ORCID http://orcid.org/0000-0002-2521-4473
Gideon SchreiberDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel. gideon.schreiber@weizmann.ac.il.ORCID http://orcid.org/0000-0002-2922-5882
Jiří ZahradníkFirst Faculty of Medicine, Charles University, BIOCEV center, Vestec, Czechia. jiri.zahradnik@lf1.cuni.cz.ORCID http://orcid.org/0000-0002-8698-4236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42649218
PMCPMC13518779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.